Back to search
Dermatology Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Dermatology Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Dermatology Disease trials you may qualify forThe purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to sever…
The project is a national, prospective, multicenter, single-arm interventional pilot of screening skin tumors in the Czech Republic. The primary aim of the pro…
The purpose of this study is to assess adults with palmoplantar keratoderma (thickening skin layer on palms and soles) who are treated with the study drug, tapi…
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
This study will evaluate the effects of oral semaglutide in combination with topical corticosteroid/calcipotriol on clinical outcomes and metabolic inflammation…
This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while t…
This study evaluates a new ozonated oil-based hair cream for women with oily scalp (seborrhea). The cream contains natural oils (moringa, wheat germ, olive, and…
Adult patients (≥18 years) with confirmed cutaneous T-cell lymphoma evaluated at Hospital México between 2019 and 2025 will be retrospectively analyzed using ED…
Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum…